Helena Jaczek
Markham—Stouffville
Ontario
Liberal
Contact
- Ottawa office
- 1 613 992-3640
- Constituency office
- 1 905 471-8963
- Office address
- Main office - Markham, 203-204 137 Main street North, Markham ON L3P 1Y2
- Parliament profile
- Parliament profile
Meetings with Helena Jaczek reported by registered lobbyists. Lobbyists must report every oral, arranged meeting with an MP, minister or other designated public office holder.
← Helena Jaczek
Markham—Stouffville
Ontario
Liberal
Newest first, back to November 2021 if Helena Jaczek held office then.
Reported by Renata Woodward · In-house (organization)
Enhancement of ecological gift program - increase in tax incentives for land donors, including cash donors towards conservation of land.
Endorse ACLT as the national representative of regional and local land trusts within the CNPF- Land Trust Conservation Fund (LTCF) to enhance the program through delivery of the outcomes related to expanding protected areas, restoring degraded landscapes, protecting species at risk, adapting to climate change, improving land management, and mobilizing private resources.
2. Create a Canada Conservation Investment Fund Establish a new $150 million endowment fund that will create a long-term funding stream to strengthen the capacity of local and regional land trusts to care for natural spaces in perpetuity. By creating an endowment fund, the Canada Conservation Investment Fund will help ensure the long-term care of Canada’s network of privately conserved areas.
Reported by Nicholas Neuheimer · In-house (organization)
Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time.
Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs.
Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.
Reported by Kate Horton · In-house (organization)
Advocating for the development of a federal capital funding program to address transitional housing needs for vulnerable populations, including families served by Ronald McDonald House.
Reported by Mike Allan · In-house (organization)
Connected Care for Canadians Act (BILL S-5) : Urging federal policy makers to adopt this legislation quickly and to ensure that it is supported by a robust set of regulations.
Efforts to reducing administrative burden for family physicians by addressing federal health forms.
Funds should be directed to supporting family medicine, as part of the Federal government's Health Infrastructure Fund announced in Budget 2025.
Fulfill key investments to support family doctors, promised by the Liberal Party during the 2025 Federal elections. This includes initiatives to provide admin burden relief, set up a new FP practice fund, and create new residency seats.
Reported by Kimberly Carson · In-house (organization)
Reported by Danielle Flieler · Consultant
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
Reported by Jackson Cardillo · Consultant
Reported by Alexis Morin · Consultant
Reported by Mallory Potter · In-house (organization)
The organization is advocating for policy and administrative improvements to the Canadian Dental Care Plan (CDCP) to ensure it aligns with clinical standards, supports fair and sustainable reimbursement for providers, and improves access to care for patients. Key areas of focus include revising eligibility criteria and treatment timelines, addressing gaps between CDCP fees and provincial fee guides, reducing administrative burden related to claims and preauthorizations, improving clarity and transparency of covered services and exclusions, and strengthening coordination of benefits with other programs. These efforts aim to enhance program efficiency, provider participation, and equitable access to oral health care across Canada.
Reported by Brad Saunders · In-house (organization)
Reported by Anthony Chiovitti · Consultant
Promoting access to oral health care for Canada's denture users, including but not limited to those living in long-term care facilities, First Nations and Inuit people, Northern Canadians, and other vulnerable populations.
Reported by Harshivam Bawa · Consultant
Secure Federal funding for and greater collaboration with the Toronto Zoo animal reproduction labs.
Reported by Brian St. Louis · Consultant
Secure Federal funding for and greater collaboration with the Toronto Zoo animal reproduction labs.
Reported by Andrea Miotti · In-house (organization)
Reported by Alex Munter · In-house (organization)
INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care.
FEDERAL HEALTH FUNDING FOR A NEW PRIMARY CARE ACCESS FUND: Recommendation for a funding commitment to ensure that every Canadian has access to a family doctor or primary care team.
PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories.
MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts.
PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to health care facilities for health care workers and patients.
NET ZERO: Advocate for sustainable health systems in Canada, including reaching net-zero emissions by 2050; advocate for the establishment of a national climate and health secretariat within the federal government to develop a pan-Canadian approach to addressing the impacts of climate change and health; and advocate for a targeted health infrastructure fund as part of the federal government’s long-term plan for public infrastructure.
TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed.
BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care.
Reported by Bolu Ogunyemi · Consultant
PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level.
PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to health care facilities for health care workers and patients.
INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care.
TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed.
MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts.
BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care.
NET ZERO: Advocate for sustainable health systems in Canada, including reaching net-zero emissions by 2050; advocate for the establishment of a national climate and health secretariat within the federal government to develop a pan-Canadian approach to addressing the impacts of climate change and health; and advocate for a targeted health infrastructure fund as part of the federal government’s long-term plan for public infrastructure.
FEDERAL HEALTH FUNDING FOR A NEW PRIMARY CARE ACCESS FUND: Recommendation for a funding commitment to ensure that every Canadian has access to a family doctor or primary care team.
Reported by Nicole DeKort · In-house (organization)
Reported by Pamela Valentine · In-house (organization)
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Reported by Stephanie Amole · Consultant
To introduce CAS leadership to federal government and to discuss potential solutions to address Canada's health human resources capacity issues and growing surgical backlogs.
Reported by Stephanie Levee · Consultant
Enhancement to Canada's regulatory and funding environment for new rare disease medicines, including Health Canada authorizations of medicines and framework for clinical trials, health technology assessment processes, reimbursement negotiations and funding decisions to improve access for rare disease patients.
Regulatory amendments and/or guidelines related to the Food and Drugs Act Regulations and Health Canada to implement an orphan drug regulatory framework.
Enhancements related to intellectual property legislation, regulations and policies applicable to rare disease medicines.
Federally-funded public drug plans, with respect to reimbursement for rare disease medicines for federal plan beneficiaries.
Implementation of the National Strategy for Drugs for Rare Diseases, and other policies or programs for rare disease medicines.
Reported by Jessica Cardill · Consultant
Reported by Elizabeth Myles · In-house (organization)
Reported by Harry Harsch · In-house (organization)
Reported by Darran Fischer · In-house (corporation)
Reported by Elizabeth Myles · In-house (organization)
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.